Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

Biotech 2050 Podcast

En podcast av: Biotech 2050

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Our American listeners can also listen to Biotech 2050 Podcast at our American site

229 Avsnitt

Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth
Publicerades 2025-03-20

Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences
Publicerades 2025-03-11
Liam Killingstad on How Family Offices Quietly Fuel Biotech’s Boldest Innovations
Publicerades 2025-03-06
Clare Terlouw, Head of LifeArc Ventures, on Bridging Biotech’s Funding Gap & Investing for Impact
Publicerades 2025-02-26
AI, Biotech, & Venture Capital: Alex Bangash, Founder of Transpose, on Future of Startup Investing
Publicerades 2025-02-20
Empowering Neurodivergent Innovators: Chad Belinsky on Impact, Mentorship, and Atypical Path
Publicerades 2025-02-12
Biotech Venture Investing with Narayan Chowdhury, Co-Founder of Franklin Park LLC
Publicerades 2025-02-06
David Meeker, CEO of Rhythm Pharmaceuticals, on Rare Disease Breakthroughs & Biotech’s Future
Publicerades 2025-01-29
Pioneering Advances in Cell Therapy: Kristin Yarema, President & CEO of Poseida Therapeutics
Publicerades 2024-11-20
Bharatt Chowrira, CEO & Eric Elenko, CoFounder & President of PureTech on Biotech Growth
Publicerades 2024-11-13
Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations
Publicerades 2024-11-06
Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson's Breakthroughs
Publicerades 2024-10-30
Revolutionizing Heart Health: Bitterroot Bio’s Bold Vision with CEO Pavan Cheruvu
Publicerades 2024-10-23
Inside the Journey of Abcuro: CEO Alex Martin on Leadership, IBM, and the Future of Biotech
Publicerades 2024-10-17
Precision Neuroscience Breakthroughs: Abe Ceesay, CEO of Rapport Therapeutics I Future of Biotech
Publicerades 2024-10-11
Dr. Dave Bearss, Co-Founder & CEO of Halia, on Pioneering Genetic Discoveries to Defeat Alzheimer’s
Publicerades 2024-10-04
Breaking Biotech Barriers: Avidity President & CEO Sarah Boyce on RNA’s Next Frontier
Publicerades 2024-09-19
Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity
Publicerades 2024-08-28
Redefining Dementia Care: CervoMed's Bold Journey with CEO John Alam
Publicerades 2024-08-15
From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas, on Rare Disease Innovation
Publicerades 2024-08-06

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

229 Avsnitt

Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth

Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences

Liam Killingstad on How Family Offices Quietly Fuel Biotech’s Boldest Innovations

Clare Terlouw, Head of LifeArc Ventures, on Bridging Biotech’s Funding Gap & Investing for Impact

AI, Biotech, & Venture Capital: Alex Bangash, Founder of Transpose, on Future of Startup Investing

Empowering Neurodivergent Innovators: Chad Belinsky on Impact, Mentorship, and Atypical Path

Biotech Venture Investing with Narayan Chowdhury, Co-Founder of Franklin Park LLC

David Meeker, CEO of Rhythm Pharmaceuticals, on Rare Disease Breakthroughs & Biotech’s Future

Pioneering Advances in Cell Therapy: Kristin Yarema, President & CEO of Poseida Therapeutics

Bharatt Chowrira, CEO & Eric Elenko, CoFounder & President of PureTech on Biotech Growth

Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations

Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson's Breakthroughs

Revolutionizing Heart Health: Bitterroot Bio’s Bold Vision with CEO Pavan Cheruvu

Inside the Journey of Abcuro: CEO Alex Martin on Leadership, IBM, and the Future of Biotech

Precision Neuroscience Breakthroughs: Abe Ceesay, CEO of Rapport Therapeutics I Future of Biotech

Dr. Dave Bearss, Co-Founder & CEO of Halia, on Pioneering Genetic Discoveries to Defeat Alzheimer’s

Breaking Biotech Barriers: Avidity President & CEO Sarah Boyce on RNA’s Next Frontier

Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity

Redefining Dementia Care: CervoMed's Bold Journey with CEO John Alam

From Banking to Biotech: Renée Aguiar-Lucander, CEO of Calliditas, on Rare Disease Innovation